Related Experiment Video
Updated: Feb 10, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Substitutions in interferon sensitivity-determining region and hepatocarcinogenesis after hepatitis C virus
Satoshi Yasuda1, Masatoshi Ishigami1, Yoji Ishizu1
1Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Background And Aim:
Amino-acid substitutions in the interferon sensitivity-determining region (ISDR) within the NS5A region are known to be associated with responsiveness to interferon (IFN)-based therapy. Additionally, previous studies reported that the ISDR was related to the development of hepatocellular carcinoma (HCC) in patients infected with hepatitis C virus (HCV). However, the association between substitutions in the ISDR and the development of HCC in patients who achieved sustained virological response (SVR) is unclear. The aim of this study was to clarify the association between amino-acid substitutions in the ISDR and development of HCC after SVR.
Methods:
One thousand five hundred eighty-eight patients infected with HCV who were treated with IFN-based therapy were enrolled, and 475 patients who achieved SVR and underwent complete virological analysis at pretreatment were investigated. HCV genotypes consisted of 1a (n = 10), 1b (n = 307), 2a (n = 110), 2b (n = 41), and 3a (n = 7), and the ISDR in each genotype was examined by direct sequencing.
Results:
Nineteen patients developed HCC after SVR. The cumulative incidence of HCC was 2.1% and 15.9% at 5 and 10 years after SVR, respectively. Multivariate analysis indicated older age (≥ 60 years: hazard ratio [HR], 3.23; P = 0.014), higher γ-glutamyl transpeptidase level (≥ 50 IU/L: HR, 8.42; P < 0.001) and ≥ 3 substitutions in the ISDR (HR, 3.24; P = 0.016) as independent factors that were significantly associated with HCC development.
Conclusion:
Amino-acid substitutions in the ISDR are useful to predict not only IFN responsiveness but also HCC development in patients who achieved SVR by IFN-based therapy.
Insights
Amino-acid substitutions in the interferon sensitivity-determining region (ISDR) predict hepatocellular carcinoma (HCC) risk in hepatitis C virus (HCV) patients after treatment. This finding aids in predicting HCC development post-sustained virological response (SVR).
Area of Science:
- Hepatology
- Virology
- Oncology
Background:
- Interferon (IFN) therapy is used for Hepatitis C Virus (HCV) infection.
- Amino-acid substitutions in the Interferon Sensitivity-Determining Region (ISDR) of the NS5A gene correlate with IFN treatment response.
- Previous research suggests a link between ISDR and Hepatocellular Carcinoma (HCC) development in HCV patients, but this is unclear post-sustained virological response (SVR).
Purpose of the Study:
- To investigate the association between ISDR amino-acid substitutions and HCC development in HCV patients who achieved SVR.
- To determine if ISDR mutations can predict HCC risk after successful HCV treatment.
Main Methods:
- Analysis of 1,588 HCV patients treated with IFN-based therapy.
- Focus on 475 patients who achieved SVR and had pretreatment virological data.
- Direct sequencing of the ISDR region for HCV genotypes 1a, 1b, 2a, 2b, and 3a.
Main Results:
- Nineteen patients developed HCC after SVR, with cumulative incidences of 2.1% at 5 years and 15.9% at 10 years.
- Multivariate analysis identified older age (≥60 years), higher gamma-glutamyl transpeptidase levels (≥50 IU/L), and ≥3 ISDR substitutions as independent predictors of HCC development.
- The hazard ratio for ≥3 ISDR substitutions was 3.24 (P=0.016).
Conclusions:
- Amino-acid substitutions in the ISDR are valuable predictors of HCC development in HCV patients achieving SVR.
- ISDR analysis can inform risk stratification for HCC in patients post-IFN therapy.
- These findings extend the utility of ISDR analysis beyond predicting IFN responsiveness.
Related Concept Videos
What are Viruses?
Trigonometric Substitution
Rationalizing Substitutions
IR Frequency Region: Fingerprint Region
Determining the pH of Salt Solutions
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

